• Palonosetron Hydrochloride in CINV/RINV: Mechanistic and Cli

  2026-04-27

  This review by Fabi and Malaguti highlights palonosetron hydrochloride as a 5-HT3 receptor antagonist with unique pharmacological properties, including higher affinity and a longer half-life, offering improved prevention of chemotherapy- and radiotherapy-induced nausea and vomiting (CINV/RINV). The paper systematically evaluates its mechanism, dosing, clinical evidence, and position in antiemetic guidelines, with implications for translational and preclinical research.

• Paroxetine Mesylate: Multi-Target Oncology and Neuropharmaco

  2026-04-27

  Explore Paroxetine Mesylate as a selective serotonin reuptake inhibitor with unique multi-kinase activity. This article offers a deep dive into its mechanistic roles in oncology and neuropharmacology, providing application-focused guidance for advanced research.

• LY2228820: Applied Workflows for Selective p38 MAP Kinase In

  2026-04-26

  LY2228820 stands out as a potent, selective p38 MAP kinase inhibitor, enabling precision in anti-inflammatory and cancer research. This article details hands-on protocols, experimental optimizations, and troubleshooting strategies, integrating the latest dual-action findings to maximize reproducibility and pathway selectivity.

• Paroxetine Mesylate: Advanced Workflows for SSRI Research

  2026-04-25

  Paroxetine Mesylate, a selective serotonin reuptake inhibitor, doubles as a multi-kinase modulator—enabling unparalleled flexibility for neuropharmacology and oncology research. This article delivers actionable protocols, real-world troubleshooting, and cross-domain insights grounded in the latest mechanistic studies.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Dual-Fluorescence Delivery

  2026-04-24

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) delivers real-time, dual-mode tracking of mRNA uptake and protein translation, setting a new standard for immune-evasive gene delivery research. Its Cap 1 structure, 5-methoxyuridine modifications, and Cy5 label enable robust, quantitative mRNA delivery and translation efficiency assays in a single integrated workflow.

• Modified Ethanol Injection for Efficient mRNA Lipoplex Deliv

  2026-04-24

  Tang et al. introduce a streamlined modified ethanol injection (MEI) method for assembling mRNA lipoplexes, enabling efficient mRNA delivery and protein expression both in vitro and in vivo. Their work demonstrates enhanced expression and immunogenicity with select lipid compositions, offering practical advances for mRNA delivery studies and translational research.

• Ademetionine (S-Adenosylmethionine): Applied Methylation Wor

  2026-04-23

  Harness the full translational power of S-adenosylmethionine (Ademetionine, SAM) for advanced methylation reactions in proteins and DNA, CNS disorder modeling, and antidepressant activity research. This article delivers workflow-driven insights, troubleshooting strategies, and key innovations for maximizing reproducibility and confidence with APExBIO’s high-purity SAM.

• Radioiodinated Balsalazide: A Selective UC Imaging Tracer in

  2026-04-23

  Sanad et al. present a rigorously optimized protocol for radioiodinating balsalazide, producing a highly selective and stable radiotracer for preclinical imaging of ulcerative colitis (UC) in mice. Their work demonstrates improved target organ uptake and stability, addressing longstanding deficiencies in radiotracer follow-up for UC models.

• HotStart Universal 2X Green qPCR Master Mix: Workflow, Tips,

  2026-04-22

  The HotStart Universal 2X Green qPCR Master Mix streamlines real-time PCR gene expression analysis with unmatched specificity and robust amplification efficiency. Explore advanced workflows, troubleshooting insights, and how innovations from recent FGFR2 fusion ICC research inform practical assay design.

• Viral-Mediated RIPK3 Degradation: Controlling Necroptosis &

  2026-04-22

  Liu et al. reveal that certain orthopoxviruses encode a viral protein (vIRD) that targets the necroptosis adaptor RIPK3 for ubiquitin-mediated proteasomal degradation, suppressing necroptotic cell death and modulating virus-induced inflammation. This mechanistic insight advances understanding of host-pathogen interactions and offers a new framework for investigating viral immune evasion strategies in cell death research.

• Tetramethylrhodamine Ethyl Ester Perchlorate: Precision Prob

  2026-04-21

  Explore how tetramethylrhodamine ethyl ester perchlorate empowers advanced mitochondrial membrane potential assays and reveals nuanced insights into mitochondrial dysfunction. This article delivers a unique scientific perspective and protocol guidance for leveraging this rhodamine-like fluorescent dye.

• Butylhydroxyanisole (BHA): Molecular Precision in Redox Modu

  2026-04-21

  Explore the unique molecular mechanisms and translational advantages of Butylhydroxyanisole (BHA) in oxidative stress research. This article delivers a new, in-depth perspective on BHA’s role in modulating redox biology and guiding assay development.

• mTORC1-IRE1a Pathway Drives Palmitate-Induced Lipotoxicity i

  2026-04-20

  This study reveals that activation of the mTORC1-IRE1a axis is central to palmitate-induced triglyceride overproduction and cell death in hepatocytes. The findings establish a mechanistic link between saturated fatty acid lipotoxicity and ER stress, highlighting new targets for metabolic disease intervention.

• Bicontinuous CART-RNA Nanoparticles: Structure and Delivery

  2026-04-20

  This study elucidates the internal morphology of RNA nanoparticles formed with amphiphilic Charge-Altering Releasable Transporters (CARTs), revealing how polymer architecture and oligonucleotide type drive the formation of disordered bicontinuous phases. These findings provide actionable design rules for developing next-generation polymer-based mRNA delivery vectors, with implications for improving translation efficiency and immune evasion.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-04-19

  Wang et al. reveal that the METTL16-SENP3-LTF signaling axis protects hepatocellular carcinoma (HCC) cells from ferroptosis and promotes tumor growth through m6A-dependent RNA regulation and altered iron homeostasis. These findings highlight new molecular targets for sensitizing HCC to ferroptosis-inducing therapies, with direct implications for developing next-generation antitumor strategies.

449 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page